Toward the development of a cephalosporin-based dual-release prodrug for use in ADEPT

Journal of Organic Chemistry

Volumn 69, Issue 23, 2004, Pages 7965-7970

  Grant, Jonathan W ^a   Smyth, Timothy P ^a  

^a UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; DRUG DOSAGE; ISOMERS; SULFUR;

CEPHALOSPORIN STRUCTURES; LACTAMASE;

ENZYMES;

7 AMINOCEPHALOSPORANIC ACID; AMINOGLUTETHIMIDE; AMINOSULFENIMINE; CEPHALOSPORIN; COUMATE; DOXORUBICIN; ENZYME INHIBITOR; ETHOXZOLAMIDE; IMIDE; MELPHALAN; PRODRUG; QUINOLONE DERIVATIVE; SULFAMIC ACID; SULFONAMIDE; SULFONE; SULFUR DERIVATIVE; TOLUENESULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ANTIBODY DIRECTED ENZYME PRODRUG THERAPY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ISOMER; MITSUNOBU REACTION;

ALKYLATION; CEPHALOSPORINS; COMBINATORIAL CHEMISTRY TECHNIQUES; MOLECULAR STRUCTURE; PRODRUGS; STEREOISOMERISM;

EID: 8644235003     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo048970i     Document Type: Article

References (24)

1. Albrecht, H. A.; Beskid, G.; Christenson, J. G.; Dietcher, K. H.; Georgopapadakou, H. H.; Keith, D. D.; Konzelmann, F. M.; Pruess, D. L.; Wei, C. C. J. Med. Chem. 1994, 37, 400-407 and references therein.
2. (a) Svensson, H. P.; Frank, I. S.; Berry, K. K.; Senter, P. D. J. Med Chem. 1998, 41, 1507-1512 and references therein,
3. (b) Hudyma, T. W.; Bush, K.; Colson, K. L.; Firestone, R. A.; King, H. D. Bioorg. Med. Chem. Lett. 1993, 3, 323-328.
4. (a) Smyth, T. P.; O'Connor, M. J.; O'Donnell, M. E. J. Org. Chem. 1999, 64, 3132-3138.
5. (b) Smyth, T. P.; O'Donnell, M. E.; O'Connor, M. J.; St Ledger, J. O. Tetrahedron 2000, 56, 5699-5707.
6. (c) Smyth, T. P.; O'Donnell, M. E.; O'Connor, M. J.; St Ledger, J. O. J. Org. Chem. 1998, 63, 7600-7618.
7. For details of an alternative dual-release prodrug nucleus, see: Shamis, M.; Lode, H. L.; Shabat, D. J. Am. Chem. Soc. 2004, 126, 1726-1731.
8. Jones, C. D.; Winter, M. A.; Hirsch, K. S.; Stamm, N.; Taylor, H. M.; Holden, H. E.; Davenport, J. D.; Krumkalns, E. V.; Suhr, R. G. J. Med. Chem. 1980, 33, 416-429 and references therein.
9. (a) Woo, L. W. L.; Howarth, N. M.; Purohit, A.; Hejaz, H. A. M.; Reed, M. J.; Potter, B. V. L. J. Med. Chem. 1998, 41, 1068-1083.
10. (b) Woo L. W.; Sutcliffe, O. B.; Bubert, C.; Grasso, A.; Chander, S. K.; Purohit, A.; Reed, M. J.; Potter, B. V. L. J. Med. Chem. 2003, 46, 3193-3196 and references therein.
11. Chetrite, G. S.; Phillipe, J. C.; Wright, F.; Pasqualini, J. R. J. Steroid Biochem. Mol. Biol. 2000, 72, 23-27.
12. (a) Yamanaka, H.; Chiba, T.; Kawabata, K.; Takasugi, H.; Masugi, T.; Takaya, T. J. Antibiot. 1985, 38, 1738-1751.
13. (b) Mobashery, S.; Johnson, M. J. Biol. Chem. 1986, 261, 7879-7887.
14. (c) López, M.; Rodriguez, Z.; Valdés, B., Velez, H.; Agüero, J.; Fini, A.; González, M. Farmaco 2001, 56, 629-631.
15. Quante, J. M.; Hoke, R. A.; Mize, P. D.; Woodward, D. L.; Millner, O. E. U.S. Patent 5,514,561, May 1996.
16. Winum, J.-Y.; Vullo, D.; Casini, A.; Montero, J.-L.; Scozzafava, A.; Supuran, C. T. J. Med. Chem. 2003, 46, 2197-2204 and references therein.
17. (a) Kresze, G.; Wucherpfennig, W. Angew. Chem., Int. Ed. Engl. 1967, 6 149.
18. (b) Levtschenko, E. S.; Kirsanov, A. V. Zh.. Org. Khim. 1962, 32, 161-165.
19. (c) Levtschenko, E. S.; Kirsanov, A. V. Zh.. Org. Khim. 1962, 32, 2256-2262.
20. -OH at the interface to generate the sulfenimine.
21. (a) Caddick, S.; Wilden, J. D.; Judd, D. B. J. Am. Chem. Soc. 2004, 126, 1024-1025 and references therein,
22. (b) Guianvarc'h, D.; Duca, M.; Boukarim, C.; Kraus-Berthier, L.; Léonce, S.; Pierré, A.; Pfeiffer, B.; Renard, P.; Arimondo, P. B.; Monneret, C.; Dauzonne, D. J. Med. Chem. 2004, 47, 2365-2374.
23. For details of an alternative side chain linkage, see: Ruddle, C. C.; Smyth, T. P. Chem. Commun. 2004, 2332-2333.
24. Tardif, S. L.; Harpp, D. N. J. Org. Chem. 2000, 65, 4791-4795.